Taking Diabetes to Heart is a multi-country study, developed by the International Diabetes Federation (IDF) in partnership with Novo Nordisk, focused on CVD awareness and knowledge among people living with type 2 diabetes. The study - the first of its kind in the world - builds on the IDF global
Cardiovascular disease (CVD) is the most prevalent cause of mortality among people with type 1 diabetes and type 2 diabetes. Learn about the strategic actions required to achieve effective diagnosis, prevention and management of CVD in the new IDF CVD in Diabetes Advocacy Toolkit.
By presenting a clear summary of the problem of measuring heart disease in people with diabetes, as well as real-world solutions, this new Diabetes and cardiovascular disease report facilitates evidenced-based decision making and encourages collaboration between different sectors. The primary audience for this report includes policy makers, policy implementers and